Tuberculosis Pulmonary
📧 Sign up to get email alerts when something new happens for Tuberculosis Pulmonary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Linezolid Dosing Strategies in Drug-Resistant TB [Phase 2]
A Phase 2 clinical trial is evaluating linezolid dosing strategies for drug-resistant tuberculosis. The study is currently listed as ACTIVE_…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) [Phase 2, Phase 3]
This document reports an update on a pragmatic Phase 2/3 trial evaluating a more effective, concise, and less toxic regimen for multidrug-re…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial investigating a rifapentine-based regimen to shorten treatment for drug-susceptible pulmonary tuberculosis,…
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis) [Phase 2, Phase 3]
A clinical trial investigated atorvastatin as a treatment adjunct for pulmonary tuberculosis in Nigeria, spanning Phase 2 and Phase 3 and no…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis [Phase 2, Phase 3]
Phase 2/3 trial evaluating two-month regimens with novel drug combinations to improve effectiveness against drug-sensitive pulmonary tubercu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment [Phase 3]
Phase 3 trial update evaluating sitafloxacin-containing regimens to shorten tuberculosis treatment in pulmonary tuberculosis; not yet recrui…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis [Phase 1, Phase 2]
A clinical trial update evaluates the efficacy of metformin for sputum conversion in patients with active pulmonary tuberculosis (Phase 1/Ph…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2 [Phase 4]
Phase 4 clinical trial update for a new IL-2–based treatment for primary smear-positive pulmonary tuberculosis.
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design [Phase 2]
Phase 2 clinical trial evaluating SQ109, high-dose Rifampicin, and Moxifloxacin in adults with smear-positive pulmonary tuberculosis using a…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis [Phase 2]
This Phase 2 trial is evaluating the safety and efficacy of blocking IL-4 with Pascolizumab in patients receiving standard therapy for pulmo…
-
CLINICAL_TRIALS trial_result · 2009-03-04Clinical Trial Update: MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis [Phase 4]
Sanofi-sponsored Phase 4 trial evaluating levofloxacin for pulmonary multidrug-resistant tuberculosis has completed.